BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11585238)

  • 1. Hyperlipidemia and cardiovascular disease after organ transplantation.
    Massy ZA
    Transplantation; 2001 Sep; 72(6 Suppl):S13-5. PubMed ID: 11585238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact and management of hyperlipidemia posttransplantation.
    Fellström B
    Transplantation; 2000 Dec; 70(11 Suppl):SS51-7. PubMed ID: 11152232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to minimize immunological and nonimmunological risk factors in the renal transplant population.
    First MR
    Transplantation; 2001 Sep; 72(6 Suppl):S20-4. PubMed ID: 11585240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipemia and long-term immunosuppression.
    Charco R
    Transplant Proc; 2002 Feb; 34(1):124-6. PubMed ID: 11959219
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies for minimizing hyperlipidemia after cardiac transplantation.
    Kirklin JK; Benza RL; Rayburn BK; McGiffin DC
    Am J Cardiovasc Drugs; 2002; 2(6):377-87. PubMed ID: 14727953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft function and other risk factors as predictors of cardiovascular disease outcome.
    Forsythe JL
    Transplantation; 2001 Sep; 72(6 Suppl):S16-9. PubMed ID: 11585239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant hyperlipidemia: mechanisms and management.
    Massy ZA; Kasiske BL
    J Am Soc Nephrol; 1996 Jul; 7(7):971-7. PubMed ID: 8829110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant hyperlipidaemia.
    Jindal RM
    Postgrad Med J; 1997 Dec; 73(866):785-93. PubMed ID: 9497947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of dyslipidemia in adult solid organ transplant recipients.
    Warden BA; Duell PB
    J Clin Lipidol; 2019; 13(2):231-245. PubMed ID: 30928441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and consequences of arterial hypertension after renal transplantation.
    Koomans HA; Ligtenberg G
    Transplantation; 2001 Sep; 72(6 Suppl):S9-12. PubMed ID: 11585243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of cardiovascular disease after renal transplantation.
    Kasiske BL
    Transplantation; 2001 Sep; 72(6 Suppl):S5-8. PubMed ID: 11585242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient.
    Kirk JK; Dupuis RE
    Ann Pharmacother; 1995 Sep; 29(9):879-91. PubMed ID: 8547738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplant coronary disease: nonimmunologic risk factors.
    Johnson MR
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S124-32. PubMed ID: 1622991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight gain and cardiovascular risk after organ transplantation.
    Baum CL
    JPEN J Parenter Enteral Nutr; 2001; 25(3):114-9. PubMed ID: 11334060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications.
    Lentine KL; Schnitzler MA; Abbott KC; Li L; Burroughs TE; Irish W; Brennan DC
    Am J Kidney Dis; 2005 Oct; 46(4):720-33. PubMed ID: 16183428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.
    Campistol JM; Grinyó JM
    Transplantation; 2001 Jun; 71(11 Suppl):SS42-51. PubMed ID: 11583488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of antilipidemic therapies in chronic renal allograft failure.
    Wanner C; Bartens W; Galle J
    Kidney Int Suppl; 1995 Dec; 52():S60-2. PubMed ID: 8587286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppression and its use in kidney transplantation].
    Paliege A; Bamoulid J; Bachmann F; Staeck O; Halleck F; Khadzhynov D; Brakemeier S; Dürr M; Budde K
    Urologe A; 2015 Oct; 54(10):1376-84. PubMed ID: 26459580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus in transplant rejection.
    Rath T
    Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors and immunosuppressive regimen after liver transplantation.
    Rossetto A; Bitetto D; Bresadola V; Lorenzin D; Baccarani U; De Anna D; Bresadola F; Adani GL
    Transplant Proc; 2010 Sep; 42(7):2576-8. PubMed ID: 20832547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.